Toggle navigation
Home
Search
Services
Blog
Contact
About
Transdermal, Non-Invasive Monitoring of Medication Ingestion-281033009
Sequella, Inc., Rockville, MD, United States
Search grants from Sequella, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Comparative Brain Tumor Consortium
Patholog-Omics - Essential Tremor in the Broader Context of Neurodegeneration
The Pathogenesis of Brain Abscess
Pathways: Large Alternate Reality Games for Education -- Assessing Performance and Play
II-NEW: MIMO Software Defined Communication Testbed for UWB Radio and Free Space Optics
Recently added grants:
Kidney PCSK9 in nephrotic syndrome
Developmental underpinnings of substantia nigra vulnerability
Elucidating Genetic and Environmental Second Hits in Racial and Ethnic Minorities with APOL1 High-Risk Genotypes
Delineating developmental programs driving tumorigenesis in triple-negative breast cancer
Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Small Business Innovation Research – Phase II (N44)
Project #
N44AA033009-001
Application #
6828889
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Sequella, Inc.
Department
Type
DUNS #
125129606
City
Rockville
State
MD
Country
United States
Zip Code
20850
Related projects
NIH 2004
N44 AA
Transdermal. Non-Invasive Monitoring of Medication Ingestion-281033009
/ Sequella, Inc.
NIH 2003
N44 AA
Transdermal, Non-Invasive Monitoring of Medication Ingestion-281033009
/ Sequella, Inc.
Comments
Be the first to comment on this grant